Compound ID | 2860
Class: Antimicrobial peptide
| Spectrum of activity: | Gram-negative |
| Details of activity: | Active against Escherichia coli, and NDM-1 harbouring Escherichia coli only in Dulbecco’s modified Eagle medium (DMEM); protein synthesis inhibitor (cannot cross eukaryotic cell membrane) |
| Description: | Natural product from Streptomyces sp.; shows only limited efficacy in Escherichia coli septicaemia in mice (maintained bacterial burden to initial inoculum concentration); a tetrapeptide |
| Institute where first reported: | Sanofi-Aventis Deutschland GmbH, Frankfurt, Germany; Sanofi R&D, Therapeutic Area Infectious Diseases, Marcy L’Etoile, France |
| Year first mentioned: | 2006 |
| Development status: | Experimental |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/11578336 |
| Citations: |
|